It seems to me that many investors interested in BRN were also not interested in catching a falling knife.
The short speculators were very successful in lowering BRN's price by very tactical selling. And they appeared to have made a profit. It will be interesting to see how many took cover last week. They may even try to repeat their strategy.
At this stage there appears to be a buy signal in the chart and the investors waiting on the sideline are jumping in.
There is even a greater number of investors that still consider BRN a story stock. Some won't be tempted until BRN announces a material contract. Others will wait for revenue. Others will wait for profit. Still others will wait for a history of profit.
I am very happy with my BRN investment, the tech seems well accepted and is certainly in the right area with a huge prospective market. I don't know of any real competitor to BRN and the market cap is still less than USD $500M with a relatively tight shareholder base. We live in interesting times.
- Forums
- ASX - By Stock
- Brainchip Short Discussion
It seems to me that many investors interested in BRN were also...
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
-0.015(5.08%) |
Mkt cap ! $552.2M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 27.5¢ | $6.297M | 22.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 1370975 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 1073647 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 1320975 | 0.275 |
48 | 1391142 | 0.270 |
14 | 575137 | 0.265 |
16 | 333306 | 0.260 |
7 | 126883 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 1073647 | 14 |
0.290 | 678311 | 14 |
0.295 | 941871 | 17 |
0.300 | 1088061 | 27 |
0.305 | 934255 | 14 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online